KIMBERLEY KNIGHT: Open Payments
NPI 1518301183 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,565 in 101 payments from 19 companies in 2025. Trend: 2023 $2,275 · 2024 $1,953 · 2025 $2,565
Food & beverage: $2,468Education: $97
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $434 |
| Insmed, Inc. | 13 | $336 |
| GlaxoSmithKline, LLC. | 15 | $275 |
| Regeneron Healthcare Solutions, Inc. | 5 | $253 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $174 |
| Actelion Pharmaceuticals US, Inc. | 3 | $162 |
| GENZYME CORPORATION | 8 | $162 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $159 |
| Viatris Specialty LLC | 5 | $103 |
| Grifols USA, LLC | 4 | $91 |
Products named: Arikayce, DUPIXENT, BREZTRI, UPTRAVI, Adempas, NUCALA, TRELEGY ELLIPTA, YUPELRI.
Industry payments across KY — which companies pay providers there.
